EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

S100B, Actor and Biomarker of Mild Traumatic Brain Injury

Charlotte Oris iD, Samy Kahouadji iD, Julie Durif iD, Damien Bouvier iD, Vincent Sapin iD

International Journal of Molecular Sciences · 01.04.2023 · 24 (7) · 6602

DOI: 10.3390/ijms24076602 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.04.2023. Verfasst von Charlotte Oris und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetic Department, University Hospital, F-63000 Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Brain Concussion, Brain Injuries. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mild traumatic brain injury (mTBI) accounts for approximately 80% of all TBI cases and is a growing source of morbidity and mortality worldwide. To improve the management of children and adults with mTBI, a series of candidate biomarkers have been investigated in recent years. In this context, the measurement of blood biomarkers in the acute phase after a traumatic event helps reduce unnecessary CT scans and hospitalizations. In athletes, improved management of sports-related concussions is also sought to ensure athletes’ safety. S100B protein has emerged as the most widely studied and used biomarker for clinical decision making in patients with mTBI. In addition to its use as a diagnostic biomarker, S100B plays an active role in the molecular pathogenic processes accompanying acute brain injury. This review describes S100B protein as a diagnostic tool as well as a potential therapeutic target in patients with mTBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain ConcussionBrain InjuriesChildAdultHumansS100 Calcium Binding Protein beta SubunitTomography, X-Ray ComputedBiomarkers

Stichwörter der Autor:innen

S100Bactorbiomarkerconcussiontraumatic brain injury

Substanzen

S100 Calcium Binding Protein beta SubunitBiomarkersS100B protein, human

Autor:innen und Institutionen

  • Biochemistry and Molecular Genetic Department, University Hospital, F-63000 Clermont-Ferrand, France.
  • Faculty of Medicine of Clermont-Ferrand, Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000 Clermont-Ferrand, France.

ORCID-Profile: Charlotte Oris, Samy Kahouadji, Julie Durif, Damien Bouvier, Vincent Sapin

Zitieren

APA

Oris, C., Kahouadji, S., Durif, J., Bouvier, D., & Sapin, V. (2023). S100B, Actor and Biomarker of Mild Traumatic Brain Injury. International Journal of Molecular Sciences, 24(7), 6602. https://doi.org/10.3390/ijms24076602

Vancouver

Oris C, Kahouadji S, Durif J, Bouvier D, Sapin V. S100B, Actor and Biomarker of Mild Traumatic Brain Injury. International Journal of Molecular Sciences. 2023;24(7):6602. doi:10.3390/ijms24076602

BibTeX
@article{Oris2023,
  author = {Oris, Charlotte and Kahouadji, Samy and Durif, Julie and Bouvier, Damien and Sapin, Vincent},
  title = {S100B, Actor and Biomarker of Mild Traumatic Brain Injury},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {7},
  pages = {6602},
  doi = {10.3390/ijms24076602}
}
Kostenlos starten →